Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program RFAV3 does not meet the regulatory requirements for proficiency testing.
- This program meets the CAP Accreditation Checklist item FLO.23737, which requires semiannual testing of antigens.
- One 1.1‑mL cell line specimen
RFAV1 and RFAV3 have stability of two days or less. The CAP cannot guarantee performance or offer credits for orders placed for shipment outside of the US and Canada.
Shipment A: May 24
Shipment B: November 29